This site is intended only for healthcare professionals resident in the Republic of Ireland

Search

Menu

Close

Sign in or RegisterLog out
Our medicinesTherapy areasExplore contentExplore contentMaterialsVideosPodcastsLet’s connectLet's connectContact usSign up
Menü
Schließen
Maternal ImmunisationMaternalMaternal Immunisation HomepageSafety ProfileDosingOlder AdultsOlder AdultsOlder Adults HomepageSafety ProfileDosingUseful ResourcesUseful ResourcesVideosMaterialsPreparationPrescribing Information

▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Refer to section 4.8 of the SmPC for how to report adverse reactions.

Please refer to the ABRYSVO Summary of Product Characteristics for full prescribing informationABRYSVO is a vaccine indicated for:
  • Passive protection against lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in infants from birth through 6 months of age following maternal immunisation during pregnancy.1
  • Active immunisation of individuals 60 years of age and older for the prevention of LRTD caused by RSV.1

The use of this vaccine should be in accordance with official recommendations.1



Maternal Immunisation with ABRYSVO

Learn more about maternal immunisation with ABRYSVO.

 Learn moreLoading
ABRYSVO in Older Adults


Find out more about the use of ABRYSVO in older adults.

 Learn moreLoading
Preparation of ABRYSVO

 

Watch a video on how to prepare ABRYSVO for administration. Learn moreLoading
Useful Resources

 

Explore the ABRYSVO resources section for useful videos and materials. VideosLoading Materials Learn more about RSV & ABRYSVO with 5-minute eModules

Lorem ipsum dolor sit amet, consectetur badipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

 eModule 1: Understand RSV disease and the at-risk populations Loading eModule 2: What is ABRYSVO?

LRTD = Lower respiratory tract disease RSV = respiratory syncytial virus

References:

  1.  Abrysvo Summary of Product Characteristics.

Legal Category: S1A
Further information is available upon request

PP-A1G-IRL-0050 Date of Preparation September 2024

Adverse events should be reported. Report an adverse event to your national reporting system (HPRA Pharmacovigilance)
 

Adverse events should also be reported to Pfizer Medical Information on 1800 633 363

PfizerPro AccountPfizerPro Account

Please sign in or register to gain access to information relating to Pfizer medicines and vaccines, medical conditions, patient materials and services.

Sign in or RegisterRegisterAccountLog out

This site is intended only for healthcare professionals resident in the Republic of Ireland. If you are a member of the public wishing to access information on a specific medicine, please visit https://www.medicines.ie

 

This website is brought to you by Pfizer Healthcare Ireland Unlimited Company, The Watermarque Building, Ringsend Road, Dublin 4, Dublin, Ireland, D04 K7N3.  Registered in the Republic of Ireland No. 127002. Directors: D. Mangone (Managing), O. Gavan, D. Kennedy. Company Secretary: M.Byrne.  

 

Copyright © 2024 Pfizer Limited. All rights reserved.
 

PP-UNP-IRL-0832. October 2024
You are now leaving PfizerPro
You are now leaving PfizerPro Ireland. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer. Pfizer accepts no responsibility for the content or services of the linked site.


PP-UNP-IRL-0832. October 2024
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​
For Healthcare Professionals in the Republic of Ireland *

The information on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland and contains promotional content.

I confirm that I am a healthcare professional* resident in the Republic of Ireland.

If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland Unlimited Company.

*The IPHA Code definition of a healthcare professional is a person of any of the following classes: (i) Registered medical practitioners (ii) Registered dentists (iii) Registered pharmacists (iv) Registered nurses

Terms of use

PP-UNP-IRL-0832. October 2024

Yes No